Screening for the chronic disorders depression, peripheral arterial disease and dementia in family practices;Screening bei der hausärztlichen versorgung der chronischen erkrankungen depression, pAVK und demenz

Zeitschrift fur Allgemeinmedizin

Volumn 82, Issue 5, 2006, Pages 199-204

  Hensler, Stefan ^a   Engeser, P ^a   Kaduszkiewicz, H ^a  

^a NONE

Author keywords

Primary care; Screening

Indexed keywords

ARTERY DISEASE; DEMENTIA; DEPRESSION; GENERAL PRACTICE; HUMAN; PRIMARY HEALTH CARE; REVIEW; SCREENING;

EID: 33646822956     PISSN: 09376801     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-933418     Document Type: Review

References (57)

1. Wittchen HU, Krause P, Höfler M, et al. Hydra-Studie. Fortschritte der Medizin 2003; Sonderheft I
2. Wittchen HU, Pittrow D. Prevalence, recognition and management of depression in primary care in Germany: the depression 2000 study. Hum Psychopharmacol Clin Exp 2002; 17: S1-S11
3. Wittchen HU, Kessler RC, Beesdo K, et al. Generalized Anxiety and Depression in Primary Care: Prevalence, Recognition and management. J Clin Psychiatry 2002; 63: 24-34
4. Diehm C, Darius H, Pittrow D, et al. Knöchel-Arm-Index. Ein wegweisender Risikomarker für die hausärztliche Praxis. Dtsch Ärztebl 2005; 102: A2310-A2313
5. Melchinger H, Machleidt W. Werden Demenzpatienten in Hausarztpraxen lege artis behandelt? Z Allg Med 2005; 81: 191-196
6. PACE-PAD-Studie: Gefäßpatienten optimal hausärztlich betreuen. Der Hausarzt 2004; 2: 83
7. Hensler S, Wiesemann A. Diskreditierende Versorgungsstudien in deutschen Hausarztpraxen. Z Allg Med 2003; 79: 579-585
8. Mistry K, Cable G. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. J Am Board Fam Pract 2003; 16: 95-101
9. Hoesl CE, Altwein JE. Early detection of cancer of the prostate. Pros and cons. MMW Fortschr Med 2005; 147: 32-36
10. Harns R, Lohr KN. Screening for prostate cancer: an Update of the evidence for the D. S. Preventive Services Task Force. Ann Intern Med 2002; 137: 917-929
11. Windeler J, Perleth M, Antes G. PSA-Screening - Die Zeit ist nicht reif. Dtsch Ärztebl 2003; 100: 2488-2489
12. Olsen O, Gøtzsche PC. Screening for breast cancer with mammography. The Cochrane Database of Systematic Reviews 2005. Issue 4
13. Baum E, Hensler S, Popert U. Risikofaktoren und Risikoindikatoren für kardiovaskuläre Erkrankungen: Prognoseverbesserung als Maßstab. Z Allg Med 2004; 80: 71-76
14. Linn LS, Yager J. The effect of screening sensitation and feedback on notation of depression. J Med Educ 1980; 55: 942-949
15. Hoeper EW, Nycz GR, Kessler LG, et al. The usefulness of screening for mental illness. Lancet 1984; 1: 33-35
16. Shapiro S, German PS, Skinner EA, et al. An experiment to change detection and management of mental morbidity in primary care. Med Care 1987; 25: 327-339
17. Magruder-Habib K, Zung WW, Feussner JR. Improving physicians recognition and treatment of depression in general medical care. Results of a randomized clinical trial. Med Care 1990; 28: 239-250
18. Dowrick C. Does testing for depression influence diagnosis or management by general practitioners? Fam Pract 1995; 12: 461-465
19. Callahan CM, Dittus RS, Tierney WM. Primary care Physicians' medical decision making for late-life depression. J Gen Intern Med 1996; 11: 218-225
20. Soon JA, Levine M. Screening for Depression in patients in long-term care facilities: a randomized controlled trial of physician response. J AM Geriatr Soc 2002; 50: 1092-1099
21. Zung WW, King RE. Identification and treatment of masked depression in a general medical practice. J Clin Psych 1983; 44: 365-368
22. Reifler DR, Kessler HS, Bernhard EJ, et al. Impact of screening for mental health concerns on health service utilization and functional status in primary care patients. Arch Intern Med 1996; 156: 2593-2599
23. Lewis G, Sharp D, Bartholomew J et al. Computerized assessment of common mental disorders in primary care: effect on clinical outcome. Fam Pract 1996; 13: 120-126
24. Williams JW, Mulrow CD, Kroenke K, et al. Case-finding for depression in primary care. A randomized trial. Am J Med 1999; 106 (1): 36-43
25. Arthur AJ, Jagger C, Lindesay J, et al. Evaluating a mental health assessment for older people with depressive symptoms in general practice: a randomised controlled trial. Br J Gen Pract 2002; 52: 202-207
26. Gilbody S, House AO, Sheldon TA. Screening and case finding instruments for depression. Cochrane Review 2005
27. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 136: 765-776
28. Katon W, Robinson P, Korff M von, et al. A multifaceted Intervention to improve treatment of Depression in primary care. Arch Gen Psych 1996; 53: 924-932
29. Katzelnick DJ, Simon GE, Pearson SD, et al. Randomized Trial of a Depression Management Program in High Utilizers of Medical Care. Arch Fam Med 2000; 9: 345-351
30. Callahan CM, Hendrie HC, Dittus RS, et al. Improving treatment of late depression in primary care: a randomized trial. J Am Geriatr Soc 1994; 42: 839-846
31. Wells KB, Sherbourne C, Duan N, et al. Quality improvement for Depression in Primary Care: Do Patients with subtreshold Depression benefit in the long run? Ma J Psychiatry 2005; 162: 1149-1157
32. Hunkeler EM, Meresman JF, Hargreaves WA, et al. Efficacy of Nurse Telehealth Care and Peer Support in Augmenting treatment of depression in primary care. Arch Fam Med 2000; 9: 700-708
33. Simon GE, Korff M von, Rutter C, et al. Randomised Trial of monitoring, feedback, and management of care by Telefone to improve treatment of depression in primary care. BMJ 2000; 320: 550-554
34. Fuchsberger F, Padberg F, Faltraco F, et al. Alzheimertherapie möglichst im Frühstadium beginnen. So bleiben Alltagskompetenzen länger erhalten. MMW Fortschr Med 2002; 144: 36-39
35. Wallesch CW. Differential- und Frühdiagnose. Hausarzt Kolleg 2002; 1: 12-15
36. Deutsche Gesellschaft für Neurologie. Diagnose und Therapie der Alzheimer-Demenz und der Demenz mit Lewy-Körperchen. http://www. uni-duesseldorf.de/WWW/AWMF/II/030-029.htm (besucht am 2.1.06)
37. Park MH, Lee DH, Lee HJ, et al. The PHC-cog: a brief cognitive function screening test for the elderly. Neurol India 2005; 53: 60-64
38. Jorm AF. Methods of screening for dementia: a meta-analysis of studies comparing an informant questionnaire with a brief cognitive test. Alzheimer Dis Assoc Disord 1997; 11: 158-162
39. Brodaty H, Clarke J, Ganguli M, et al. Screening for cognitive impairment in general practice: toward a consensus. Alzheimer Dis Assoc Disord 1998; 12: 1-13
40. White N, Scott A, Woods RT, et al. The limited utility of the Mini-Mental State Examination in screening people over the age of 75 years for dementia in primary care. Br J Gen Pract 2002; 52: 1002-1003
41. U.S. Preventive Services Task Force. Screening for dementia: recommendation and rationale. Ann Intern Med 2003; 138: 925-926
42. Patterson CJ, Gauthier S, Bergman H, et al. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ 1999; 160 (Suppl 12): S1-S15
43. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004; 109: 733-739
44. Vogt MT, McKenna M, Anderson SJ, et al. The relationship between ankle-arm index and mortality in older men and women. J Am Geriatr Soc 1993; 41: 523-530
45. Belch JJ, Topol EJ, Agnelli G, et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003; 163: 884-892
46. Stoffers HE, Rinkens PE, Kester AD, et al. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 1996; 25: 282-290
47. Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004; 172: 95-105
48. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-1324
49. Schwartz LM, Woloshin S, Fowler FJ Jr, et al. Enthusiasm for cancer screening in the United States. JAMA 2004; 291: 71-78
50. Schilling FH, Spix C, Berthold F, et al. Neuroblastom-Früherkennung im Alter von einem Jahr in Deutschland - eine kontrollierte populationsbezogene Studie mit unerwartetem Ausgang. Dtsch Ärztebl 2003; 100: 1739-1746
51. Koch K. PSA-Test und Prostatakarzinom, Ein Beispiel für das Dilemma der Früherkennung. Dtsch Ärztebl 2003; 100: 1955-1957
52. Mühlbauer I, Steckelberg A. Aufklärung über Krebsfrüherkennung am Beispiel Mammographie- und Darmkrebs-Screening. Z Allg Med 2005; 81: 523-527
53. Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004; 328: 921-924
54. Goffmann E. Stigma - Über Techniken der Bewältigung beschädigter Identität. Suhrkamp Verlag, Frankfurt/Main 1974
55. Dörner K. In der Fortschrittsfalle. Dtsch Arztebl 2002; 99: A 2462-A 2466
56. Tijmstra T, Spikers W, Broer J, et al. Psychosocial consequences of screening for microalbuminuria and for some other risk factors. Ned Tijdschr Geneeskd 2000; 144: 2460-2464
57. Windeler J. Prävention: Screening auf dem Prüfstand. Dtsch Arztebl 2002; 100: A5